Milovan Stojanović
University of Nis(RS)Institute for Cardiovascular Diseases of Vojvodina(RS)
Publications by Year
Research Areas
Blood Pressure and Hypertension Studies, Atrial Fibrillation Management and Outcomes, Cardiac Arrhythmias and Treatments, Heart Rate Variability and Autonomic Control, Antiplatelet Therapy and Cardiovascular Diseases
Most-Cited Works
- → Stroke prevention in atrial fibrillation and ‘real world’ adherence to guidelines in the Balkan Region: The BALKAN-AF Survey(2016)58 cited
- → Beta blocker rebound phenomenon is important, but we do not know its definition, incidence or optimal prevention strategies(2020)24 cited
- → Compelling Indications Should be Listed for Individual Beta-Blockers (Due to Diversity), Not for the Whole Class(2020)14 cited
- → Certain beta blockers (e.g., bisoprolol) may be reevaluated in hypertension guidelines for patients with left ventricular hypertrophy to diminish the ventricular arrhythmic risk(2021)14 cited
- → A Discrepancy: Calcium Channel Blockers Are Effective for the Treatment of Hypertensive Left Ventricular Hypertrophy but Not as Effective for Prevention of Heart Failure(2022)13 cited
- → High likelihood for atrial fibrillation in Cushing's syndrome.(2020)13 cited